News in the Life Sciences Industry | |
Results 481 - 500 out of 500 displayed. | |
« 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 |
Merck to Collaborate with Donghao Lansheng to Pilot New Import Policy in China |
SHANGHAI, Nov. 8, 2020 /PRNewswire/ -- On November 6, Merck, a leading science and technology company, announced the signing of a Letter of Intent with Donghao Lansheng... Read more ›› |
By: PR Newswire Association LLC. - 08 Nov 2020 |
Merck to Collaborate with Donghao Lansheng to Pilot New Import Policy in China |
SHANGHAI, Nov. 8, 2020 /PRNewswire/ -- On November 6, Merck, a leading science and technology company, announced the signing of a Letter of Intent with Donghao Lansheng... Read more ›› |
By: PR Newswire Association LLC. - 08 Nov 2020 |
Merck to Collaborate with Donghao Lansheng to Pilot New Import Policy in China |
SHANGHAI, Nov. 8, 2020 /PRNewswire/ -- On November 6, Merck, a leading science and technology company, announced the signing of a Letter of Intent with Donghao Lansheng... Read more ›› |
By: PR Newswire Association LLC. - 08 Nov 2020 |
Merck and Transcenta Collaborate to Advance Continuous Biomanufacturing, Make the 'Facility of the Future' a Reality |
SHANGHAI, Nov. 8, 2020 /PRNewswire/ -- On November 7, Merck, a leading science and technology company, and Transcenta, a global biotherapeutics company, announced a strategic technology... Read more ›› |
By: PR Newswire Association LLC. - 08 Nov 2020 |
Merck and Transcenta Collaborate to Advance Continuous Biomanufacturing, Make the 'Facility of the Future' a Reality |
SHANGHAI, Nov. 8, 2020 /PRNewswire/ -- On November 7, Merck, a leading science and technology company, and Transcenta, a global biotherapeutics company, announced a strategic technology... Read more ›› |
By: PR Newswire Association LLC. - 08 Nov 2020 |
Merck and Transcenta Collaborate to Advance Continuous Biomanufacturing, Make the 'Facility of the Future' a Reality |
SHANGHAI, Nov. 8, 2020 /PRNewswire/ -- On November 7, Merck, a leading science and technology company, and Transcenta, a global biotherapeutics company, announced a strategic technology... Read more ›› |
By: PR Newswire Association LLC. - 08 Nov 2020 |
Merck and Transcenta Collaborate to Advance Continuous Biomanufacturing, Make the 'Facility of the Future' a Reality |
SHANGHAI, Nov. 8, 2020 /PRNewswire/ -- On November 7, Merck, a leading science and technology company, and Transcenta, a global biotherapeutics company, announced a strategic technology... Read more ›› |
By: PR Newswire Association LLC. - 08 Nov 2020 |
Invitation to Active Biotech’s virtual capital markets day |
Read more ›› |
By: GlobenewsWire - 06 Nov 2020 |
Related companies: Active Biotech AB |
Trading in Novo Nordisk shares by board members, executives and associated persons on 4 and 5 November 2020 |
Read more ›› |
By: GlobenewsWire - 06 Nov 2020 |
Trading in Novo Nordisk shares by board members, executives and associated persons on 4 and 5 November 2020 |
Read more ›› |
By: GlobenewsWire - 06 Nov 2020 |
Strong Sobi presence at American Society of Hematology 2020 Annual Meeting |
STOCKHOLM, Nov. 6, 2020 /PRNewswire/ -- Sobi(TM) will present data at the 62nd Annual Meeting of the American Society of Hematology (ASH) taking place taking place as a virtual meeting from 5-8 December. Twelve abstracts featuring five treatments have been accepted for presentation during ASH,... Read more ›› |
By: PR Newswire Association LLC. - 06 Nov 2020 |
Related companies: Swedish Orphan Biovitrum AB (Sobi™) | Sobi |
Two new members of ALK’s Board of Directors |
Read more ›› |
By: GlobenewsWire - 06 Nov 2020 |
Navamedic ASA: Q3 2020 financial results |
OSLO, Norway, Nov. 6, 2020 /PRNewswire/ -- Navamedic ASA (OSE: NAVA) grew revenues by 16% in the third quarter of 2020 compared to the same quarter last year. The company reported revenues of NOK 56.8 million in the third quarter of 2020 with an EBITDA of NOK 3.8 million, driven by both new... Read more ›› |
By: PR Newswire Association LLC. - 06 Nov 2020 |
Related companies: Navamedic ASA |
Johnson & Johnson Innovation Announces Three Strategic Collaborations with a Focus on Advancing Healthcare Solutions in China |
SHANGHAI, Nov. 6, 2020 /PRNewswire/ -- Johnson & Johnson Innovation, division of Johnson & Johnson (China) Investment Limited, announced today three new collaborations with strategic partners in China at the third China International Import Expo (CIIE) in Shanghai. These latest collaborations,... Read more ›› |
By: PR Newswire Association LLC. - 06 Nov 2020 |
Elekta's newest radiotherapy system, Elekta Harmony, receives CE mark |
STOCKHOLM, Nov. 6, 2020 /PRNewswire/ -- Elekta (EKTA-B.ST) announced today that it has received CE mark for its Elekta Harmony* linear accelerator (linac), clearing the technology for commercial sales in Europe. Initially, Elekta will introduce Harmony throughout Europe and other countries where... Read more ›› |
By: PR Newswire Association LLC. - 06 Nov 2020 |
Related companies: Elekta AB |
Medicover : Interim report July-September 2020 |
STOCKHOLM, Nov. 6, 2020 /PRNewswire/ -- Read more ›› |
By: PR Newswire Association LLC. - 06 Nov 2020 |
Related companies: Medicover AB |
Moberg Pharma intends to distribute and separately list BupiZenge® (BUPI) |
STOCKHOLM, Nov. 6, 2020 /PRNewswire/ -- The Board of Directors of Moberg Pharma AB (OMX: MOB) today announces its intention to distribute the operations of BupiZenge(®) (BUPI) to the shareholders of Moberg Pharma by distributing 90 percent of the shares in a subsidiary (name to... Read more ›› |
By: PR Newswire Association LLC. - 06 Nov 2020 |
Related companies: Moberg Pharma AB (Publ) |
Moberg Pharma decides on fully guaranteed rights issue of approximately SEK 150 million |
STOCKHOLM, Nov. 6, 2020 /PRNewswire/ -- The Board of Directors of Moberg Pharma AB (publ) (OMX: MOB) ("Moberg Pharma" or "the Company") has today resolved to carry out a fully guaranteed issue of new ordinary shares and warrants ("Units") with preferential rights for existing shareholders... Read more ›› |
By: PR Newswire Association LLC. - 06 Nov 2020 |
Related companies: Moberg Pharma AB (Publ) |
Invitation to Presentation of Immunovia´s Interim Report January - September 2020 on November 12, 2020 |
LUND, Sweden, Nov. 6, 2020 /PRNewswire/ -- Immunovia invites to a teleconference (in English) for investors, analysts and media on Thursday, November 12, 2020 at 16:30 CET. Immunovia will publish the company's interim report on November 12, 2020 at 16:00 CET. Read more ›› |
By: PR Newswire Association LLC. - 06 Nov 2020 |
Related companies: Immunovia AB |
Vicore Pharma Holding AB (publ) publishes the interim report for the third quarter 2020 |
GOTHENBURG, Sweden, Nov. 6, 2020 /PRNewswire/ -- Read more ›› |
By: PR Newswire Association LLC. - 06 Nov 2020 |
« 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 |
Upcoming Life Sciences Events
- January 2021
- BioSeed Digital 2021
- NutrEvent
- AgeingFIT
Latest company news
There are currently no news available for this portal